Swing To Trade
  • Stock
  • Politics
  • Business
  • Sports
Stock

Cannabis stocks soar on Trump reclassification speculation

by admin August 11, 2025
August 11, 2025

Following a Wall Street Journal report, cannabis stocks surged Monday due to speculation that US President Donald Trump is considering reclassifying marijuana to a lower danger level.

Canopy Growth and Tilray Brands both saw surges of over 12% on Monday. 

Cronos Group climbed more than 5%, reaching a new 52-week high in early trading, according to a CNBC report.

Similarly, the AdvisorShares Pure US Cannabis ETF (MSOS) and Amplify Alternative Harvest ETF (MJ) each experienced gains exceeding 10%.

Low price point

Many cannabis stocks in the sector trade at remarkably low prices, often less than a dollar per share. 

This low price point means that even small fluctuations of a few cents can translate into substantial percentage changes in stock value, making these stocks highly volatile. 

Despite a recent rally, which saw some positive movement on Monday, the majority of these cannabis stocks remain far below their historical all-time highs. 

Investors in this sector are currently navigating a high-risk landscape, where the potential for significant gains is accompanied by an equally high risk of further declines. 

The future trajectory of these stocks will largely depend on evolving regulatory frameworks, improved market demand, and the ability of individual companies to execute sustainable business models.

Earlier this month, Trump discussed the issue at a fundraiser held at his New Jersey golf club, according to attendees.

Federal change

Under US federal law, the classification of cannabis as a Schedule I drug places it in the most restrictive category, signifying a high potential for abuse and no accepted medical use. 

This categorisation, which includes substances like heroin and cocaine, has significant implications for research, medical applications, and legal enforcement. 

Historically, discussions regarding the reclassification of cannabis have often revolved around moving it to Schedule III. 

This less restrictive category includes drugs with a moderate to low potential for physical and psychological dependence, such as anabolic steroids and certain pain medications like Tylenol with codeine. 

Such a reclassification would acknowledge potential medical benefits and facilitate further research into its therapeutic applications, while still maintaining some federal control. 

The ongoing debate highlights a significant divergence between federal law and the increasing number of states that have legalized cannabis for medical or recreational use, creating a complex legal and regulatory landscape.

Reclassification benefits

Reclassifying marijuana companies would bring about various advantages, including different tax regulations and increased investment appeal.

Tim Seymour, investing chief at Seymour Asset Management, was quoted in the CNBC report on Monday, stating that a shift from Schedule 1 to Schedule 3 could “change the game” for the approximately $80 billion market. 

He also observed that this change appears to have bipartisan backing.

It does not mean that it won’t be a complicated trade,” Seymour said. “But it does mean that you’re investing now well ahead of a lot of institutional capital if you are, in fact, investing into this sector.

While Trump’s support can improve the prospects for reclassifying the drug, he lacks the unilateral authority to do so. 

The power to reclassify substances under the Controlled Substances Act rests with the Attorney General, who has historically delegated this authority to the administrator of the Drug Enforcement Administration.

The post Cannabis stocks soar on Trump reclassification speculation appeared first on Invezz

previous post
Ford to invest $2 billion in Kentucky plant to expand affordable EV production
next post
SoundHound stock soars 15% on raised revenue outlook: here’s why analysts are calling it ‘hidden gem’

Related Posts

Rivian reportedly planning layoffs, stocks spikes 1%

October 23, 2025

Nvidia’s Jensen Huang says this company is invaluable...

October 23, 2025

Should quantum computing stocks accept Trump’s offer of...

October 23, 2025

NBA figures arrested in federal probe linking gambling...

October 23, 2025

SMCI stock price decline on lowered Q1 outlook...

October 23, 2025

Krispy Kreme shares rise amid meme stock buzz...

October 22, 2025

Which direction might Tesla stock move after its...

October 22, 2025

Nvidia stock: is the Dominican Republic’s AI hub...

October 22, 2025

Why D-Wave stock is emerging as billionaires’ favourite...

October 22, 2025

Meta cuts 600 AI Jobs as part of...

October 22, 2025
Join The Exclusive Subscription Today And Get Premium Articles For Free

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Recent Posts

    • Rivian reportedly planning layoffs, stocks spikes 1%

      October 23, 2025
    • Nvidia’s Jensen Huang says this company is invaluable for next-gen AI breakthroughs

      October 23, 2025
    • Should quantum computing stocks accept Trump’s offer of federal funding?

      October 23, 2025
    • NBA figures arrested in federal probe linking gambling and organized crime

      October 23, 2025
    • SMCI stock price decline on lowered Q1 outlook may be overdone: here’s why

      October 23, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 SwingToTrade.com All Rights Reserved.

    Swing To Trade
    • Stock
    • Politics
    • Business
    • Sports